EFFECTIVENESS OF MOLECULAR-GENETIC DIAGNOSTICS DURING PERTUSSIS INFECTION FOCI EXAMINATION

Cover Page


Cite item

Full Text

Abstract

Purpose: whooping cough diagnostics by molecular-genetic methods.

Materials and methods. Under observation there were 4930 people during the period from 2012 to 2015. All samples were received in 8 schools of Moscow and the Moscow region: in 3 schools had been found children with whooping cough, in other 5 schools – only children with prolonged cough. Whooping cough diagnosis had been given earlier by bacteriological and serological methods. 430 clinical samples were studied by 2 methods: PCR with fluorescent hybridized detection of amplified products and isothermal amplification.

Results. In three of eight schools whooping cough cases at 7 children at the age of 7, 9, 11 and 15 years were revealed earlier. The diagnosis of whooping cough at them was confirmed by means of bacteriological and serological methods. 33 positive DNA samples (7.7%) are revealed. DNA-positive samples are allocated from 18 pupils and 15 employees of schools. In two schools where earlier infection sources were established, 15 DNA-positive samples from which in three cases clinical manifestations were observed are revealed. In those schools where it wasn’t earlier established a source of an infection and examinations conducted it is long the coughing children, 18 DNA-positive samples are revealed, and in two cases clinical manifestations in the form of cough were observed.

Conclusion. Performed research confirmed high efectiveness of molecular-genetic methods during pertussis infection foci examination in schools for infection source identification also amongst long coughing children. 

About the authors

A. S. Pimenova

G.N. Gabrichevsky Institute of Epidemiology and Microbiology

Email: fake@neicon.ru

Junior Researcher, Laboratory of Diagnostics of Diphtheria and Pertussis Infections,

Moscow

Россия

O. Yu. Borisova

G.N. Gabrichevsky Institute of Epidemiology and Microbiology;
The Russian National Research Medical University named after N.I. Pirogov

Author for correspondence.
Email: olgborisova@mail.ru

PhD, MD (Medicine), Associate Professor, Head of Laboratory of Diagnostics of Diphtheria and Pertussis Infections, 125212, Moscow, Admiral Makarov str., 10;

Professor of Department of Microbiology and Virology,

Moscow

Россия

O. V. Tsvircun

G.N. Gabrichevsky Institute of Epidemiology and Microbiology

Email: fake@neicon.ru

PhD, MD (Medicine), Head Researcher of Laboratory of Whooping Cough and Measles,

Moscow

Россия

A. S. Basov

G.N. Gabrichevsky Institute of Epidemiology and Microbiology

Email: fake@neicon.ru

Junior Researcher, Laboratory of Whooping Cough and Measles,

Moscow

Россия

V. A. Aleshkin

G.N. Gabrichevsky Institute of Epidemiology and Microbiology

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Director,

Moscow

Россия

S. S. Afanasiev

G.N. Gabrichevsky Institute of Epidemiology and Microbiology

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Deputy Director for Biotechnology Department,

Moscow

Россия

E. E. Donskich

The Russian National Research Medical University named after N.I. Pirogov

Email: fake@neicon.ru

PhD (Biology), Associate Professor, Associate Professor of Department of Microbiology and Virology,

Moscow

Россия

A. P. Pikina

The Russian National Research Medical University named after N.I. Pirogov

Email: fake@neicon.ru

Assistant Professor, Department of Microbiology and Virology,

Moscow

Россия

L. I. Kafarskaya

The Russian National Research Medical University named after N.I. Pirogov

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Head of the Department of Microbiology and Virology,

Moscow

Россия

M. S. Afanasiev

Sechenov Moscow State Medical University

Email: fake@neicon.ru

PhD, MD (Medicine), Professor of the Department of Clinical Allergology and Immunology,

Moscow

Россия

A. V. Karaulov

Sechenov Moscow State Medical University

Email: fake@neicon.ru

RAS Full Member, PhD, MD (Medicine), Professor, Head of the Department of Clinical Allergology and Immunology,

Moscow

Россия

References

  1. Онищенко Г.Г. Эпидемиологическое благополучие населения России // Журнал микробиологии, эпидемиологии и иммунобиологии. 2013. № 1. С. 42–51. [Onischenko G.G. Epidemiological well-being of population of Russia. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2013, no. 1, pp. 42–51. (In Russ.)]
  2. Пpадед М.Н., Яцышина С.Б., Селезнева Т.С., Малинина С.В., Биpюлева Н.В., Любимова Т.Е., Воpобьева Н.С. ПЦР-диагностика инфекций, вызванных B. pertussis, B. parapertussis и B. bronchiseptica // Клиническая лабораторная диагностика. 2013. № 1. С. 53–56. [Praded M.N., Yatsyschyna S.B., Selezneva T.S., Malinina S.V., Birulyeva N.V., Lubimo va T.Ye., Vorobyeva N.S. The kit of reagents for polymerase chain reaction diagnostic of infections caused by B. pertussis, B. paraper tussis and B. bronchiseptica. Klinicheskaya laboratornaya diagnostika = Clinical Laboratory Diagnostics, 2013, no. 1, pp. 53–56. (In Russ.)]
  3. Селезнева Т.С., Титова Н.С., Заргарьянц А.И., Максимова Н.М., Маркина С.С. Влияние вакцинопрофилактики на эпидемический процесс управляемых инфекций в Российской Федерации // Эпидемиология и инфекционные болезни. 2002. № 2. С. 6–11. [Selezneva T.S., Titova N.S., Zargaryants A.I., Maksimova N.M., Markina S.S. Effect of vaccination on the epidemic process of vaccine-preventable diseases in Russian Federation. Epidemiologiya i infektsionnye bolezni = Epidemiology and Infectious Diseases, 2002, no. 2, pp. 6–11. (In Russ.)]
  4. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека: инфекционная заболеваемость в Российской Федерации за январь-декабрь 2015 года. [Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka: infektsionnaya zabolevaemost’ v Rossiiskoi Federatsii za yanvar’-dekabr’ 2015 goda]. URL: http://rospotrebnadzor.ru/activities/statistical-materials/statictic_details.php?ELEMENT_ID=5525 (07.10.2016)
  5. Centers for Disease Control and Prevention (CDC). Pertussis – United States, 1997–2000. MMWR Morb. Mortal. WKLY Rep., 2002, vol. 51, no. 4, pp. 73–76.
  6. Centers for Disease Control and Prevention (CDC). Pertussis Epidemic – California, 2014. MMWR Morb. Mortal. WKLY Rep., 2014, vol. 63, no. 48, pp. 1129–1132.
  7. Centers for Disease Control and Prevention (CDC). Pertussis Epidemic – Washington, 2012. MMWR Morb. Mortal. WKLY Rep., 2012, vol. 61, no. 28, pp. 517–522.
  8. King A.J., Van Gаkom T., Van der Heide H.G., Advani A., Van der Lee S. Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift? BMC Genom., 2010, no. 11: 64. doi: 10.1186/1471-2164-11-64
  9. Litt D.J., Jauneikaite E., Tchipeva D., Harrison T.G., Fry N.K. Direct molecular typing of Bordetella pertussis from clinical specimens submitted for diagnostic quantitative (real-time) PCR. J. Med. Microbiol., 2012, vol. 61, no. 12, pp. 1662–1668. doi: 10.1099/jmm.0.049585-0
  10. Stone B.L., Daly J., Srivastava R. Duration of Bordetella pertussis polymerase chain reaction positivity in confirmed pertussis illness. J. Pediatric Infect. Dis. Soc., 2014, vol. 3, no. 4, pp. 347–349. doi: 10.1093/jpids/piu004
  11. Qin X. Resurgence of whooping cough and the role of laboratory diagnosis. Clin. Microbiol. News Lett., 2015, vol. 37, no. 9, pp. 69–76.
  12. Qin X., Galanakis E., Martin E.T., Englund J.A. Multitarget PCR for diagnosis of pertussis and its clinical implications. J. Clin. Microbiol., 2007, vol. 45, no. 2, pp. 506–511.
  13. Rodgers L., Martin S.W., Cohn A., Budd J., Marcon M., Terranella A., Mandal S., Salamon D., Leber A., Tondella M.L., Tatti K., Spicer K., Emanuel A., Koch E., McGlone L., Pawloski L., Lemaile-Williams M., Tucker N., Iyer R., Clark T.A., Diorio M. Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis – Ohio, 2010–2011. Clin. Infect. Dis., 2013, vol. 56, no. 3, pp. 322–331. doi: 10.1093/cid/cis888
  14. Van Amersfoorth S.C., Schouls L.M., Van der Heide H.G., Advani A., Hallander H.O., Bondeson K., Von König C.H., Riffelmann M., Vahrenholz C., Guiso N., Caro V., Njamkepo E., He Q., Mertsola J., Mooi F.R. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol., 2005, vol. 43, no. 6, pp. 2837–2843.
  15. World Health Organization. WHO-recommended surveillance standard of pertussis. URL: www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/pertussis_standards/en (07.10.2016)

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Pimenova A.S., Borisova O.Y., Tsvircun O.V., Basov A.S., Aleshkin V.A., Afanasiev S.S., Donskich E.E., Pikina A.P., Kafarskaya L.I., Afanasiev M.S., Karaulov A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies